LATEST ARTICLES

Clinical Research Site Space: Will it Consolidate?

Clinical Research Site Space: Will it Consolidate? Clinical sponsors and clinical research sites drive clinical research in the United...

Global Clinical Trials 2019: Accelerating Breakthroughs

TrialSite News celebrates its six-month birthday with the end of 2018.  We track, monitor and report on global clinical trials with an emphasis on...

2018 Global BioPharma IP Law Round Up

TrialSite News completes the year with excitement. Founded as a simple and straightforward site to contribute to the cause of transparency in clinical research...

Diabetes Drug Costs: More Patients and Higher Costs

TrialSite News seeks to bring transparency to clinical trials and the overall drug development industry. With a focus on research sites, we also include...

Vendor Watch: Have You Heard of TrialSpark? We Break it Down For You

Who is TrialSpark? TrialSite News recently covered a start-up called TrialSpark as they made some upbeat recent industry announcements including a partnership with multi-national global...

Moderna Therapeutics: Developing the Software of Life

Introduction: A Biotech Unicorn Is Born Moderna Therapeutics (Moderna) seeks to transform drug development with messenger RNA therapeutics. Developing a next generation in vivo platform...

PriceWatch: A Sampling of Advanced Cancer Drug Prices

To understand estimated treatment cost, TrialSite News reviewed some of the most innovative cancer drugs on the market. Powerful innovations have led to new...
Pharma Utah

Tolero Pharmaceuticals: A Utah Success Story In the Making

Introduction to Tolero Pharmaceuticals Inc. Tolero Pharmaceuticals (Tolero) recently announced more data for their ongoing Phase 2 trial evaluating Alvocidib for MCL-1 Dependent Relapsed or...

The Pediatric Brain Cancer Fight Wages On

TrialSite News was recently contacted by a reader in the United States with a request for a summary of pediatric brain tumor clinical research...

Novartis’ Investments Evidencing the Shift from Volume to Value?

Swiss biopharmaceutical giant, Novartis, is the seventh largest pharmaceutical company by revenue, worldwide. The result of a series of mergers in the 1990's, the...